Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

hMG

Phase 3Small molecule

hMG is one of 39 small molecule programs targeting Infertility. It is currently in Phase 3.

1

Indications

11

Total Trials

2

Active Trials

38

Competitors

Pipeline

Status by Indication[3][1]

Indication

InfertilityActive, not recruiting

InfertilityPhase 3

Active, not recruiting

Competition

Competitive Landscape

121 competitors in Infertility

#DrugCompanyPhaseTrials

Voltaren

Victoza

Depo-Provera

Activella

Zoladex

Gonal-F

Alli

EEngelhard Arzneimittel GmbH & Co.KG

Prograf

VVeloxis Pharmaceuticals

Human Chorionic Gonadotropin

Estradiol Valerate

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2028

Phase 3Recruiting

Infertility

NCT07216742

Q2 2029

Phase 3Recruiting

Efficacy and Safety

NCT07340827

Clinical

Trials by Indication[1]

Ovarian Stimulation2 trials

Gonadotropin Type in Ovarian Stimulation

Completed·IIVI Madrid·Phase 4·NCT02437032·100 enrolled

Comparative Assessment of the Clinical Utility of Ovarian Stimulation With Menotropin Versus Menotropin Plus GnRH Antagonist

Completed· Ferring logo

Ferring··NCT01331733·131 enrolled

Intrauterine Insemination1 trial

Assessment of the Effectiveness of Menopur in Intrauterine Insemination

Completed· Ferring logo

Ferring··NCT01354834·207 enrolled

Efficacy and Safety1 trial

A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)

Recruiting· Merck & Co. logo

Merck & Co.·Phase 3·NCT07340827·333 enrolled

Ovulation1 trial

Role of Aromatase Inhibitor to Enhance Ovulation in Poor Responder During Induction With Short Antagonist Protocol in Cases of ICSI

Completed·MMinia University·Phase 4·NCT02741154·50 enrolled

Infertility1 trial

Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.

Recruiting·GGranata Bio Corporation·Phase 3·NCT07216742·659 enrolled

5 more indications

In Vitro Fertilization1 trial

Ovarian Stimulation With Recombinant Gonadotropins vs. Human Menopausal Gonadotropin in In Vitro Fertilization

Completed·UUniversity of Turin, Italy··NCT02322398·848 enrolled

Embryo Transfer1 trial

Letrozole and Sequential Clomiphene to Improve the Outcome of Embryo Transfer

Unknown status·NNavy General Hospital, Beijing·N/A·NCT02775877·100 enrolled

Prevention1 trial

hMG or Recombinant FSH on OHSS Prevention in PCOS Patients Undergoing IVF

Completed·ZZekai Tahir Burak Women's Health Research and Education Hospital·Phase 4·NCT01365936·80 enrolled

Randomized Controlled Trial1 trial

Randomized Controlled Trial Comparing Embryonic Quality in rFSH Versus hMG in IVF Protocol With GnRH Antagonist

Completed·HHospital de Clinicas de Porto Alegre·Phase 4·NCT02412904·188 enrolled

Unspecified1 trial

Miniflare Versus Long Protocol in Poor Responders

Unknown status·WWoman's Health University Hospital, Egypt·N/A·NCT02681536·200 enrolled

Sources

References

[1]
ClinicalTrials.gov — 11 trial records for hMG. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — hMG compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for hMG. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Ferring company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: Ferring

Related News